Oncotarget

Corrections:

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer

PDF  |  How to cite

Oncotarget. 2018; 9:31787-31787. https://doi.org/10.18632/oncotarget.25958

Metrics: PDF 745 views  |   ?  

Yang Chen1,*, Weishuai Liu2,*, Peng Wang3, Hailing Hou1, Ningbo Liu1, Linlin Gong1, Youyou Wang1, Kai Ji2, Lujun Zhao1 and Ping Wang1

1 Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
2 Department of Pain Management, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research, Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
3 Department of Radiation Oncology, Peking University International Hospital, Beijing 102206, China
* These authors have contributed equally to this work

Published: August 03, 2018

This article has been corrected: The correct author affiliation is given below:

1 Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China

Original article: Oncotarget. 2016; 7:71341-71352. DOI: https://doi.org/10.18632/oncotarget.11217.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25958